Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer
Interventions: RADIATION: yttrium Y 90-edotreotide
Sponsor: Novartis Pharmaceuticals